Home › Trial NCT02167919
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
- Trial IDNCT02167919
- StatusCompleted
- PhaseN/A
- Study typeInterventional
- SponsorUniversity of North Carolina, Chapel Hill
- Enrollment15
- Start date2014-07
- ConditionsBenign Prostatic Hyperplasia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.